scispace - formally typeset
F

Fernando Luiz Affonso Fonseca

Researcher at Federal University of São Paulo

Publications -  413
Citations -  3091

Fernando Luiz Affonso Fonseca is an academic researcher from Federal University of São Paulo. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 22, co-authored 350 publications receiving 2321 citations.

Papers
More filters
Journal Article

The use of vancomycin with its therapeutic and adverse effects: a review.

TL;DR: The main adverse effects of vancomycin are: hypotension, phlebitis, nephrotoxicity, ototoxicity, hypersensitivity reactions, red man syndrome, neutropenia, chills, fever, interstitial nephritis.
Journal ArticleDOI

Characterization of cell-free circulating DNA in plasma in patients with prostate cancer.

TL;DR: Cell-free circulating DNA levels were measured by a quantitative real-time PCR method with a set of primers targeted to amplify the consensus ALU apoptotic versus necrotic origin and all patients after 6 months demonstrated DNA released at non-apoptotic cell.
Journal ArticleDOI

Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis

TL;DR: Bisphosphonates are effective in preventing bone loss in patients with PC who are under ADT and could be reached without major side effects (cardiovascular or gastrointestinal events).
Journal ArticleDOI

AMH: An ovarian reserve biomarker in assisted reproduction.

TL;DR: The role of AMH in assisted reproduction outcomes is discussed and it is suggested that AMH is strongly associated with oocyte yield after ovarian stimulation and could therefore be capable of predicting the ovarian response and the quality of oocytes and embryos.
Journal ArticleDOI

IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients

TL;DR: In summary, IL-6 and TNF-α levels were associated with early mortality of CAP patients and longer admission levels demonstrated greater likelihood of early death and overall mortality.